January 20, 2012
Drug buyer plaintiffs in a putative antitrust class action accusing Braintree Laboratories Inc. of initiating baseless patent litigation to block a generic version of the laxative MiraLax asked a Delaware federal judge Friday to approve a $17.25 million settlement of direct purchaser claims.
July 07, 2011
A federal judge in Delaware ruled Thursday that Braintree Laboratories Inc. must continue to do business with direct purchasers who filed a putative antitrust class action accusing the company of initiating baseless patent litigation to block a generic version of the laxative MiraLax.
April 22, 2011
Plaintiffs in a putative antitrust class action accusing Braintree Laboratories Inc. of initiating baseless patent litigation to block a generic version of the laxative MiraLax asked a Delaware federal court Thursday to bar the company from retaliating against them.